Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2010
10/28/2010CA2759160A1 3-azabicyclo [4.1.0] heptanes used as orexin antagonists
10/28/2010CA2757055A1 Solid forms of an azocyclic amide
10/28/2010CA2756654A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/28/2010CA2745596A1 Thiazolyl-benzimidazoles
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2242753A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof
10/27/2010EP2242752A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
10/27/2010EP2242741A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
10/27/2010EP2099761B1 Antibacterial quinoline derivatives
10/27/2010EP1891057B1 Azabicyclo[3.1.0]hexane derivaives as dopamin d3 receptor modulators
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010CN1918156B Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
10/27/2010CN1720240B Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN101874030A Pyrrolidines and piperidines as orexin receptor antagonists
10/27/2010CN101874029A Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/27/2010CN101874028A 2-aza-bicyclo[3.3.0]octane derivatives
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41893 Epothilone derivatives
10/26/2010US7820824 As labeling reagents for a variety of biological applications
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820704 Substituted heteroaryl derivatives, compositions, and methods of use
10/26/2010US7820682 3-{[(3R)-1-(3,5-dimethoxy-4-methylbenzoyl)-5-(2-phenylethyl)-3-pyrrolidinyl]oxy}benzoic acid methyl ester; treatment of urinary system disease; anticarcinogenic agent, antiarthritic agent, treats proliferative disease, inflammation/immune system disease, Sjogren*s syndrome, brain-related disease
10/26/2010US7820680 HIV integrase inhibitors
10/26/2010US7820673 Urea derivative, process for producing the same, and use
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820654 such as 1-[2-(3-Chloro-4-methoxy-phenylamino)-6-phenyl-pyrimidin-4-yl]-piperidin-4-ol for treating atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by low expression of Perlecan
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2353627C Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010120741A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/21/2010WO2010119984A1 3-aryl or heteroaryl-substituted indole derivative
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010118852A1 ( pyrazol-3-yl) -1, 3, 4-thiadiazol-2-amine and ( pyrazol-3-yl) -1, 3, 4-thiazol-2-amine compounds
10/21/2010WO2010097604A3 Guanidino-substituted bi- and polyphenyls as small molecule carriers
10/21/2010WO2010077101A3 Novel thiazolidinedione derivative and use thereof
10/21/2010WO2010068761A3 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
10/21/2010WO2009020470A3 Cgrp receptor antagonists
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267708 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
10/21/2010US20100267707 Tyrosine Kinase Inhibitors
10/21/2010US20100267706 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758587A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/21/2010CA2758484A1 Anti-viral compounds
10/20/2010EP2241566A1 A method for the separation and purification of epothilones
10/20/2010EP2240475A1 Thiazole derivatives used as pi 3 kinase inhibitors
10/20/2010EP2240474A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/20/2010EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2240178A1 Prolyl hydroxylase inhibitors
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868459A Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/20/2010CN101868457A (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
10/20/2010CN101868455A Therapeutic substituted lactams
10/20/2010CN101864187A Dye with low energy level difference, intermediate and preparation method and application thereof
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/20/2010CN101863856A Bi(4-methyl-1,2,3-thiadiazole-5-phenurone) compounds and preparation method and application thereof
10/19/2010US7816379 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate
10/19/2010US7816377 such as 1-methyl-piperidin-2-carbonsaure-[1-({1-[2-hydroxy-2-(4-phenethylcarbamoyl-thiazol-2-yl)-ethyl]-2-methyl-propyl}-methylcarbamoyl)-2-methyl-butyl]-amide, used for the treatement of adenocarcinoma
10/19/2010US7816376 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816349 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
10/19/2010CA2437409C Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118063A2 Therapeutic compositions and related methods of use
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117662A1 Modulators of s1p and methods of making and using
10/14/2010WO2010117085A1 Aryl indole derivatives
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 628